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The low pa-de~ndent fusion of lipid membrane induced by two types of the fatty acylated influenza viral 
hemag~utinin has been studied by use of an energy transfer assay. When protein bound fatty acids were 
released from the hemagglutinin by hydroxylamine treatment viral fusion activity was inhibited. The extent 
of fusion inhibition correlates with the amount of fatty acids cleaved from the hemagglutinin. Virosomes 
prepared from fowl plague virus containing fatty acid free h~a~lutinin showed a much iower fusion activ- 
ity than control virosomes containing fatty acylated hema~utinin. The hydroxylamine treatment applied 
has no detectable ffects on the virus other than fatty acid release from its spike giycoproteins. These results 
support our previous hypothesis that protein bound fatty acids are involved in the induction of membrane 
fusion by the influenza hemagglutinin. 
Acylprotein Hernaggiutinin Fusion Hydroxylamine 
1. INTRODUCTION 
The fusion between lipid bilayers is a central step 
in many inter- and intracellular processes as well as 
during virus-cell interactions [l--3]. Enveloped 
viruses utilized as fusogens have revealed that their 
fusogenic membrane proteins are acylated with 
long chain fatty acids in a membrane near location 
[4]. To test for the functional significance of pro- 
tein bound fatty acids in fusion we have initiated 
a study to compare the biological activities of viral 
acyIproteins with or devoid of their fatty acid 
chains. 
It is known that hydroxylarnine releases ester- 
type linked fatty acyl chains [5,6] and we have 
recently reported that this cleavage of fatty acids 
from acylproteins reduces their hemolytic activity 
[7]. Since hemolysis alone is a questionable criteria 
for membrane fusion and difficult to quantitate, 
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we made use of a resonance energy transfer assay 
181 to monitor in a sensitive and quantifiable man- 
ner the fusion between viral or vesicular lipid 
bilayers with fluorescent target liposomes [9-121. 
The results reported here indicate a correlation 
between the presence of protein bound fatty acids 
and the fusion activity of the hemagglutinins of 
different influenza viruses. 
2. MATERIALS AND METHODS 
2.1. Cells, virus, lube&! procedures and 
polyacrylamide gel electrophoresis (PAGE) 
Chicken embryo fibroblasts (CEF) or Madin- 
Darby canine kidney cells (MDCK) were grown in 
Dulbecco’s medium. At confluency chick embryo 
cells were infected with fowl plague virus (FPV, 
H7Nl) and MDCK cells with virus N (HlON7), 
both influenza A viruses. For fatty acid labeling 
the growth medium was supplemented with 
50 &i/ml of [3H]paImitic acid. AlternativeIy, 
FPV was grown in embryonated eggs and purified 
from the allantoic fluid by differential centrifuga- 
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tion. For details of virus purification and PAGE 
see [7]. 
2.2. Fusion assays through hemolysis and 
resonance energy transfer 
2.2.1. Hemolysis assay 
Virus was adsorbed for 10 min at 4°C to a 1% 
suspension of chicken erythrocytes in 0.9% NaCl 
in a total volume of 1.2 ml before the pH was ad- 
justed usually to pH 5.5 by adding 200 ~1 of a 1 M 
sodium acetate buffer. The mixtures were cen- 
trifuged after a 30 min incubation at 37°C for 
5 min at 3000 rpm and the optical densities of the 
supernatants recorded at 540 nm. The efficiency 
and the maximal extent of hemolysis varied 
somewhat with the batch of erythrocytes utilized 
for each assay. The maximum value (A540nrn of 
0.90-1.10) was taken as 100%. 
2.2.2. Preparation of liposomes and virosomes 
Large unilamellar vesicles (LUV) were prepared 
by reverse-phase vaporation (REV) in liposome 
buffer (100 mM NaCl, 10 mM Tris-HCl, 0.2 mM 
EDTA, 0.2 mM NaNJ), adjusted to pH 7.2 [13]. 
Viral or host cell lipids were used as a source for 
liposomal bilayer lipid. Phospholipid was deter- 
mined as inorganic phosphate by the ammonium 
molybdate method [ 141. The target liposomes con- 
tained 0.8 mol%, respectively, of N-(7-nitro-2,1,3- 
benzoxadiazol)dioleoylphosphatidylethanolamine 
(N-NBD-PE) and N-(lissamine-rhodamine-B- 
sulfonyl)dioleoylphosphatidylethanolamine (N- 
Rho-PE), all purchased from Avanti Biochemicals 
(Birmingham, USA). They were sized by extrusion 
with type SM 11307 Sartorius filters (Gottingen, 
FRG). Vesicles containing the viral glycoproteins 
(designated virosomes) were prepared from octyl- 
P-D-glucoside extracts from purified virus by the 
slow detergent dialysis procedure [ 151. 
2.2.3. Fusion assay by resonance energy transfer 
The resonance energy transfer (RET) assay was 
principally performed as described by Stegmann et 
al. [lo] using a Perkin Elmer MPF 2A fluorospec- 
trophotometer thermostatted at 37°C. Samples 
were incubated in a total volume of 2.7 ml 
liposome buffer containing the equivalent of 
10rmol phospholipid of labeled and 50pmol of 
unlabeled liposomes. After adsorption (5 min) the 
pH was adjusted by adding 100 ,ul of a 1 M sodium 
128 
acetate solution of the appropriate pH value and 
the increase of N-NBD-PE fluorescence was 
recorded at 530 nm. Incubations were terminated 
by adding Triton X-100 to a final concentration of 
0.1% to measure maximal dequenching. 
2.3. Fatty acid cleavage from influenza 
hemagglutinin by hydroxylamine 
Deacylation of radiolabeled viral spike 
glycoprotein (HA) was as described before [7]. In- 
cubation mixtures were diluted at least IO-fold for 
the hemolysis assay and 50-fold for the RET test. 
Fatty acid release was monitored by PAGE and 
fluorography. Radioactivity present in viral 
glycoproteins was quantitated by densitometric 
tracing of fluorograms. 
2.4. Hemagglutination assay 
A standard procedure was used throughout with 
1% chicken erythrocytes in 0.9% NaCl. Usually 
50~1 samples of either virus or virosomes were 
serially diluted and the hemagglutinin titres record- 
ed 45 min after adding the blood cells. 
3. RESULTS 
3.1. Fusion activity resides in the viral HA 
Before investigating the possible participation of 
protein bound fatty acids 1201 in membrane fusion 
we verified first that fusion is induced exclusively 
by the viral acylprotein. Influenza virus induced 
fusion requires an acidic milieu and a hemag- 
glutinin (HA) cleaved into a large (HAr) and a 
small fragment (HAz) [3,16,17]. Avian influenza 
virus N grown in MDCK cells is not fusogenic nor 
infectious because of its uncleaved HA. A short in 
vitro treatment with trypsin activates viral infec- 
tivity due to the upper mentioned cleavage of HA 
into HAi and the fatty acylated HA2 [18,19]. Us- 
ing this virus we can show an increase of N-NBD- 
PE fluorescence in our fusion assay only after 
trypsin activation (fig.1, upper scan). In contrast 
to virus N, FPV does contain the cleaved form of 
the HA spike glycoprotein, so that the fusogenic 
HA2 is readily available. Its involvement in fusion 
under our conditions was verified by the complete 
proteolytic digestion of the HA spikes, which led 
to a drastic inhibition of fusion between ‘naked’ 
virus particles and target liposomes in the RET test 
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Fig.1. Fusion induced by trypsin activated virus N. 
Arrows at (a) mark the addition of virus N to the mixed 
target liposomes at neutral pH. At (b) the pH is adjusted 
to pH 5.5 by adding 1 M sodium acetate. For activation 
of virus N, trypsin (15 pg/ml final concentration) is 
added (c, upper scan only). The maximum value is 
reached by adding Triton X-100 (d). Fusion activity is 
not detectable without activation by trypsin (lower 
scan). 
(not shown). Both virus species were only active in 
hemolysis and fusion at a pH below 5.6 (fig. 1, see 
below). 
3.2. Effect of fatty acid release on the fusion 
activity of the influenza virus HA 
When FPV was incubated with increasing con- 
centrations of hydroxylamine at 37°C prior to the 
RET fusion assay, a direct correlation between the 
doses of the drug and the inhibition of fusion and 
hemolytic activity was observed (fig.2a,b). Addi- 
tionally, the degree of fusion inhibition depended 
on the duration of the respective incubation of 
virus particles with NH20H (fig.2a). Essentially 
the same results were obtained with trypsin ac- 
tivated virus N, which has an HA type (HlO) dif- 
ferent from FPV (H7) (not shown). As depicted in 
fig.3, the temperature used for the incubation with 
the drug is also crucial for the extent of inactiva- 
tion. A 5 min treatment with 1 M hydroxylamine 
at 0°C reduced viral fusion activity only marginal- 
ly while a 1 min, and even more so a 5 min, prein- 
cubation at 37°C inhibited the increase of 
fluorescence at 530 nm to 23% and almost 0% of 
the control value obtained with virus analysed im- 
mediately after adding hydroxylamine (100%). As 
with fusion activity the extent of fatty acid 
cleavage from the HA2 of [3H]palmitic acid labeled 
a 4 
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0 10 20 30 40 
PKEINCUBATIOR (MIN) 
Fig.2. Effect of hydroxylamine on FPV induced fusion 
and hemolysis. (a) After preincubation of FPV (216 
HAU) with NHzOH at 37°C fusion activity was 
quantitated by RET. NaCl-treated virus was tested as 
control. The control level of fusion (defined as 1OOvo n 
the ordinate) represents 40% fluorescence increase at 
530 nm as compared to the maximum value obtained 
after addition of Triton X-100. (b) FPV particles 
(equivalent to 1600 HAU) were preincubated with 
hydroxylamine (1 .O and 0.3 M) at 37°C for the indicated 
time periods and hemolysis measured. 
FPV depended on the concentration of hydrox- 
ylamine used for deacylation. However the release 
of only a portion of the label is already quite effec- 
tive in fusion inhibition (cf. fig.2 and table 1). 
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Fig.3. Fusion kinetics of FPV pretreated with 1 M 
NHzOH (pH 6.5) at 0°C ( -) and 37°C (---) for the 
indicated time periods as quantitated by RET. 0 min 
values (defined as 100%) refer to samples taken from the 
preincubation mixture immediately after adding 
hydroxylamine. As in fig.2a the control values are 
equivalent to 40% fluorescence as compared to the 
maximum values reached after addition of Triton X-100. 
Although the reason for this feature is not known 
with certainty it may be due to a preferential 
release of the most fusogenic acyl species (e.g. oleic 
acid) present in the acylprotein [1,20]. 
Since a 30 min treatment with 1 M hydrox- 
ylamine at 37°C (pH 6.6) in addition to acyl 
cleavage from HA may potentially have other ef- 
fects on the structural integrity of virus particles, 
their lipid composition, adsorption activity 
(hemagglutination) and immunoreactivity were 
tested. No major differences could be detected (not 
shown). To ensure that the HA2 polypeptide itself 
is not damaged in any other way than just by 
release of the covalently bound acyl chains, this 
protein was isolated from polyacrylamide gels and 
subjected to proteolytic fingerprint and endgroup 
analysis. No difference in the HA fragment pat- 
terns could be detected and the latter analysis 
yielded the amino-terminal amino acid sequence 
Gly-Leu-Phe for both control and NHZOH-treated 
HA2 of FPV. These data indicate that inhibition of 
fusion by hydroxylamine is due to the release of 
fatty acids from the HA2 polypeptide. 
Virosomes bearing acylated or fatty acid free In contrast to the fusogenic polypeptide of other 
glycoproteins on their surface were prepared by paramyxoviruses Sendai virus F-protein cannot be 
dialysis of octyl-P-D-glucoside extracts from labeled with [3H]palmitic acid ([ 191, Schmidt and 
NHzOH- or NaCl-treated FPV. As shown in fig.4 RoDmann, unpublished). Therefore we compared 
control virosomes were more fusogenic (graph C) its sensitivity to hydroxylamine with other 
than the virosomes containing deacylated HA enveloped viruses which do contain fusion active 
(graph D). It is noteworthy that a reduction of fu- acylproteins. The results in table 2 demonstrate 
sion activity from -40% to lo-15% (relative to 
the 100% values reached with detergents) was 
observed with the control preparations (intact FPV 
treated with 1 M NaCl) as a result of overnight 
dialysis (unpublished). For this reason the inhibi- 
tion of fusion by hydroxylamine in this experiment 
appears to be not as severe as shown for the non- 
dialysed virus (cf. fig.3). 
Table 1 
Release of fatty acids from HA2 of [3H]palmitic acid labeled FPV by 
hydroxylamine 
Percent radioactivity in hemagglutinin 
0 mina 5 min 10 min 20 min 30 min 
Control (1 M NaCl) 100 100 100 100 100 
NHzOH (0.3 M) 100 - 83 - 62 
NH2OH (0.6 M) 100 _ 66 _ 31 
NH2OH (1.0 M) 100 78 51 24 22 
a Duration of incubation at 37°C prior to PAGE analysis followed by 
densitometry. The mean values of duplicate analyses are shown 
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Fig.4. Kinetics of fusion induced by virosomes. Fusion was induced by FPV (equivalent o 2” HA units) incubated for 
200 min in PBS (A) or 1 M NHzOH (B) at 37°C followed by dialysis or by virosomes with acylated (C) or fatty acid 
free HA2 (D) derived from samples A and B (left panel). The Coomassie patterns of viral polypeptides after PAGE 
of the samples tested for fusion activity show no differences (right panel). The viral proteins are designated as follows: 
NP, nucleoprotein; NA, neuraminidase; HA112 , hemagglutinin; M, matrixprotein. 
that fusion activity of all viruses with acylated 
spike proteins is inhibited by NHzOH whereas the 
Sendai virus even shows a somewhat increased 
hemolytic activity. 
Table 2 
Effect of hydroxylamine on hemolysis 
Virus Acylproteins pHa Control Hydroxyl- 
amineb 
SFV El,E2 5.2 0.720 0.058 
FPV HA2 5.5 0.619 0.041 
FPV HA2 6.8 0.005 0.008 
Virus N HA2 5.2 0.598 0.035 
Virus N HA2 6.8 0.010 0.006 
NDV F-protein 6.8 1.242 0.805 
Sendai virus none 6.8 0.490 0.661 
a pH during hemolysis test 
b Treatment was for 30 min at 37°C with 1 M NH2OH 
at pH 6.5 
4. DISCUSSION 
Hydroxylamine has been used as a reagent for 
virus inactivation long before its protein 
deacylating properties were discovered [5,21]. 
While its effect was then attributed to the 
modification of the viral genomic nucleic acids, 
NHzOH has also been used for the cleavage of 
specific peptide bonds [22]. 
Despite this potential our control experiments 
reveal that neither the viral structural integrity nor 
the HA polypeptide itself were effected by the 
NHzOH treatment applied here. Although as yet 
unknown NHzOH-sensitive molecular require- 
ments for fusion cannot be excluded completely, it 
is compelling to postulate that the inhibition of 
membrane fusion by hydroxylamine described in 
this report is due to the release of fatty acids from 
the hemagglutinin protein. This hypothesis is sup- 
ported by the finding that fusion inhibition by 
hydroxylamine works also with other enveloped 
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viruses (e.g. SFV) which contain fatty acylated 
fusogenic spike proteins but not with Sendai virus, 
the F-protein of which is apparently not acylated. 
Thus, NHzOH does not represent a general 
‘fusion-blocker’ but seems to exert its effect only 
via the fatty acid cleavage from fusogenic acylpro- 
teins thereby implicating that fatty acids are not 
generally required for a protein to induce mem- 
brane fusion. However, once present in such pro- 
teins, the bound acyl chains may represent crucial 
triggers for this process. 
Numerous studies have indicated an involve- 
ment of the hydrophobic amino-terminus of 
fusogenic viral polypeptides in membrane fusion 
[16-18,231. Furthermore at least with the influen- 
za HA it seems clear that intra- as well as inter- 
molecular rearrangements occur prior to the merg- 
ing of the two lipid bilayers involved [ 12,241. The 
conclusions drawn from the results presented here 
are compatible with other hypotheses on the 
molecular mechanism of fusion proposed 
previously [3,12,24]. It is conceivable that protein 
linked fatty acids operate in concert with the above 
mentioned polypeptide regions to form an even 
bulkier hydrophobic ‘drill’ for both the close at- 
traction of the viral lipid bilayer to the target mem- 
brane and its destabilisation to facilitate the fusion 
process. 
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